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Interaction of pore-forming toxins, syringopeptin22A (SP22A), syringomycin E (SRE) and syringotoxin (ST), with model membranes
were investigated. Liposomes were prepared from saturated phospholipids (DPPC or DMPC) or from binary mixtures of DPPC with varying
amount of DOPC or cholesterol. The effects of the three toxins on the molecular order and dynamics of the lipids were studied using electron
paramagnetic resonance (EPR) techniques. SP22A was the most-, SRE less-, and ST the least effective to increase the ordering and to
decrease the rotational correlation time of the lipid molecules. The effects were more pronounced: (a) on small unilamellar vesicles (SUVs)
than on multilamellar vesicles (MUVs); (b) on pure DPPC than on DPPC–cholesterol or DPPC–DOPC mixtures. Fluidity changes,
determined from EPR spectra at different concentrations of the toxin, suggested the shell structure of the lipid molecules in pore formation.
EPR spectra observed at different depth of the hydrocarbon chain of the lipid molecules implied an active role of the lipid molecules in the
architecture of the pores created in the presence of the three toxins. Temperature dependence of the fluidity of the SUVs treated with toxins
has shown an abrupt and irreversible change in the molecular dynamics of the lipid molecules at a temperature close to the pretransition,
depending on the toxin species and the lipid composition. Coalescence and aggregation of the SUVs were proposed as the origin of this
irreversible change.
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Membrane-permeabilizing compounds are widespread
weapons in the nature used as part of the host defense system
of many species from insects to mammalians, and as toxins
of pathogenic bacteria [1–11]. The structure of these pep-
tides and lipopeptides are very different but mainly it shows
an amphiphilic structure in hydrophobic environment, and
possesses one or more positive charges [1,2,4,6,12–15]. The
spectrum of the activity and the efficiency of these molecules
depend on both the structure of the molecule and the lipid
composition of the target membrane. Extensive studies on
pore-forming endogenous host-defense peptides highlighted
the requirement for appropriately positioned cationic resi-
dues [1,2,4]. Sitaram et al. [16,17] showed that the arrange-
ment of charged residues was important for the activity and
an increased net positive charge enhanced the antimicrobal
activity in case of seminalplasmin, a 47-residue protein iso-
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thermore, a positive charge added to the N-terminus of
pardaxin, an icthytoxic peptide, increased the antibacterial
activity and enhanced hemolytic activity [18]. Studies on
analogues of seminalplasmin and melittin indicated that the
hydrophobic momentum of these pore-forming compounds
also plays an important role in their activity [4,19].
In this article, another important family of the mem-
brane-permeabilizing compounds, the cyclic lipodepsipep-
tides (CLPs), is considered. CLPs produced by the
phytopathogen Pseudomonas syringae pv. syringae have
also antifungal and antibacterial activity [20–22], which
makes them promising compounds to human treatment.
CLPs showed different antimicrobal-, hemolytic- and plant
pathogenic activity that can be explained by the different
structures of these toxins. CLPs have a charged cyclic
peptide head and a hydrophobic 3-hydroxy-fatty acid tail
of variable length (Fig. 1). There are two groups of the
CLPs. The first group includes the nonapeptides: syringo-
mycins (SRs) [12–14], syringotoxin (ST) [23], syringos-
tatins [14] and pseudomycins [24], while the second
includes the larger syringopeptins (SPs) [25]. The number
of charges and the hydrophobicity of CLPs are variable,Fig. 1. Schematic structure of the CLPs used in the present study.
Abbreviations of the essential amino acids correspond to the generally
accepted ones. Abbreviations for the nonessential aminoacids are: Dab: 2,4-
diaminobutanoic acid; Dhb: 2,3-dehydro-2-aminobutyric acid; Hse: homo-
serine; Orn: ornithine.which suggested having a deterministic role in the activity
[26]. The most studied CLP is the nonapeptide syringo-
mycin E (SRE), which possesses a peptide lactone ring
with three positive and one negative charges, and a 3-
hydroxy-fatty acid tail. The other nonapeptide, ST, studied
by us has only two positive charges in addition to one
negative on its peptide head, completed with a 3-hydroxy-
fatty acid tail. The syringopeptins contain a polar peptide
lactone ring built up by eight amino acid residues and has
two positive charges. The polar peptide head is joined to
the hydrophobic 3-hydroxy-fatty acid tail by a great
peptide moiety, which is composed of 14 (SP22A,
SP22B) or 17 (SP25A, SP25B) mainly hydrophobic amino
acid residues. Thus, the size and the hydrophobicity of SPs
are much greater than that of SR or ST. The syringopeptins
have stronger phytotoxic activity than the nonapeptides
[20,21]. CLPs showed antifungal activity, although differ-
ent fungal species display different degrees of sensitivity
[20,22]. Activity of CLPs is significantly influenced by the
lipid composition of the membrane; e.g., the antifungal
activities are affected especially by sphingolipids and
sterols [27–30]. Lipid involvement in CLP action was
also shown with planar bilayer membrane (BLM) and
human red blood cells (RBCs) [31–33].
It was shown in earlier studies that SRE, SP22A and ST
induce pores on BLM and RBC membrane; SP22A had the
highest pore-forming activity, while SRE had less and the
weakest was ST [26,34,35]. SRE and ST showed a temper-
ature-dependent pore inactivation. Shorter mean lifetime of
the pores was found with ST, than with SRE at 20 and 37
jC. In contrast, SP22A-pores did not inactivate. It was
suggested that these differences are the consequences of
the variance of hydrophobicity and the number of charges
[26].
All the above results highlighted the fact that the
structure and the charge both of the pore-forming com-
pounds and the membrane lipids are substantial in the
activity. Thus, an investigation of the molecular interac-
tions between the toxins and lipids is essential in order to
understand the effect and in favor of rational drug
development. Electron paramagnetic resonance (EPR)
spectroscopy is a versatile tool to monitor molecular level
interactions, which can be different depending on the CLP
species and the lipid composition of the model mem-
branes. We focused our study on CLPs acting on lip-
osomes prepared from saturated lipids, DPPC and DMPC.
We addressed also the questions: (a) How do CLPs affect
the structure of model membranes? (b) How does DOPC,
an unsaturated lipid, or cholesterol influence the interac-
tions between the lipids and the CLPs? We monitored the
membrane at different depths along the hydrocarbon chain
using spin-labeled fatty acids. EPR spectral parameters
were used to characterize the membrane fluidity; more-
over, rotational dynamics and steric constrains involved in
the specific interactions were also determined by simulat-
ing the experimental EPR spectra.
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2.1. Materials
Cholesterol and synthetic dipalmitoyl-L-a-phoshati-
dylcholine (DPPC), dimyristoyl-L-a-phoshatidylcholine
(DMPC), dioleoyl-phosphatidylcholine (DOPC), of mini-
mum 99% purity, were obtained from Sigma Chemical Co.
7-doxyl (SL-7) and 12-doxyl-stearic acid (SL-12) spin
labels were obtained from ICN Biomedicals Inc., Ohio.
16-doxyl-stearic acid (SL-16) spin label was from Sigma
Chemical, 5-doxyl-stearic acid (SL-5) spin probe was pur-
chased from Aldrich Chemical Co, 1-palmitoyl-2-
stearoyl(5-DOXYL)-sn-glycero-3-phosphocholine was ob-
tained from Avanti Polar Lipids INC. SP22A and SRE were
purified to homogeneity as described earlier [36] and stored
frozen. ST was purified to homogeneity as previously
published [36] from cultures of P. syringae strain PS268
[37] obtained from D.C. Gross (Texas A & M University,
College Station, TX, USA). The CLPs used in our study
were a gift from J.Y. Takemoto, Utah State University, USA.
Solutions of phosphate buffered saline (PBS) were made
from tablets purchased from Oxoid Ltd., Hampshire, Eng-
land. Ethanol was of analytical grade purchased from
Reanal, Hungary.
2.2. Preparation of liposomes
Lipids and the chosen spin label (1 mol%) were dissolved
in ethanol. The organic solvent was evaporated with nitrogen
stream under continuous rotation of the vessel. The rest of
the solvent was removed from the lipid film in 30 min using
a vacuum-line and the samples were stored in a desiccator
overnight. The dry lipid film was re-hydrated gently above
the main transition temperature (at about 50 jC) with PBS
(pH: 7.4). To produce multilamellar vesicles (MLV), the
dispersion (130 mg lipid/ml) was vortexed for 20 min at
50 jC. To prepare small unilamellar vesicles (SUVs) with
different composition, dispersion (10 mg lipid/ml) of the
hydrated lipid film was sonicated two times for 10 min,
with 10-min pause between sonications, at 50 jC. A
Soniprep 150 MSE sonicator was used with frequency of
20 kHz and wave amplitude of 8 Am. The size distribution
of the SUV samples was checked by dynamic light
scattering (DLS) using an ALV Goniometer. The goniom-
eter was equipped with a Spectraphysics 124B He-Ne laser
operating at 10 mW with a wavelength of 632.8 nm. Sam-
ples were diluted to the appropriate concentration (f 1
mg/ml) range for the DLS measurements.
The typical hydrodynamic radius of the vesicles was
between 30 and 40 nm with a half-width of about 10 nm.
2.3. Treatment with CLPs
In case of SUVs, 50 Al of liposome dispersion was mixed
with an appropriate quantity of toxin (SP22A, SRE or ST)stock solution (1 mg/ml in 10 3 M HCl). The CLP/lipid
molar ratio used in this study was in the range of 1:40 to
1:800. To check if addition of the CLP’s solution does not
modify the pH of the final suspension, we added the
corresponding volumes of 10 3 M HCl solution to PBS
and measured the pH. According to this test the highest
change in the pH was 0.2. Three protocols were used for the
incubation: (a) cold treatment, (b) ambient treatment and (c)
warm treatment. Cold treatment: before the incubation at 0
jC, all the solutions used were cooled down in ice–water
mixture. Liposome dispersion was mixed with the appro-
piate CLP solution and shaken thoroughly at 5-min incuba-
tion time. Aliquots from the sample were put into the EPR
tubes maintained also in an ice–water mixture. For the
samples prepared at ambient temperature (ambient treat-
ment) care has been taken not to exceed 20–23 jC during
the CLP treatment before measuring the EPR spectrum. In
the warm treatment, samples and the CLP solutions were
preheated. Samples were treated with the given CLP for 5–
10 min at about 37–38 jC in a cell culture thermostat.
In case of MLV, stock solution of the toxin was added to
the sample after the rehydration of the lipid film and
vortexed for 20 min at ambient temperature to ensure the
appropriate mixing of CLPs and lipids.
2.4. ESR spectroscopy
Technical details. EPR spectra were recorded with an X-
band Bruker EMX6 on-line spectrometer equipped with a
standard rectangular cavity. Modulation frequency was 100
kHz with amplitudes between 0.3 to 2.0 G, depending on
the spin label and the sample temperature. For the SL-16
spin label, the maximal amplitude of 0.8 G was chosen
below the pretransition temperatures to avoid overmodula-
tion, and it was decreased to 0.3 G at greater temperatures.
Similarly, for the other spin labels the modulation ampli-
tudes were greater below the pretransition temperature by
0.5–1.0 G than above the pretransition temperature. Cen-
tered at 3400 G, 2048 spectral points were taken in a 100-G
interval. Acquisition time was 183 or 366 s with appropriate
time constants. The microwave power was 15 mW in the
case of SL-5 and SL-7, and 10 mW for the SL-12 and SL-16
spin labels.
Samples were measured in quartz capillaries with inside
diameters of about 1.2 mm, centered in the cavity by a
special sample holder designed by us. The temperature of
the samples was measured and controlled by a fine-wire
thermocouple immersed into the sample, and was stabilized
with a precision of 0.1 jC with a purpose-built closed
circuit, nitrogen-gas system based on Peltier-diodes. Tem-
perature range covered in the present measurements was
between 2 and 50 jC.
Evaluation of the EPR spectra. To characterize the
membrane fluidity in the case of the spin labels SL-5
and SL-7, we used the parameter 2Amax, the outer-peak
separation. In a limited range of temperatures (2–25 jC),
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satisfying precision also for the SL-12. However, for SL-
12 and SL-16, it was necessary to use the ratio of the
amplitudes of the low-field peak (h+ 1) to the center-peak(ho) (Fig. 2) to characterize the fluidity over the whole
temperature range.
To simulate the EPR spectra the latest version of the
nonlinear least-squares (NLLS) program developed and
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Among other parameters, this program allows determination
of the rotational tensor component, Rprp, and the ordering
potentials, which are connected to the rotational correlation
times, and the spatial constrain of the molecular Brownian-
motion, respectively. A further quantity is generally derived
to characterize the fluidity: the commonly used order
parameters, S20, which describes the molecular alignment
relative to the main alignment axis. The magnetic parame-
ters used in the calculations were based on earlier experi-
mental and computational results [38,41]. In spectral fitting
of the EPR spectra measured with SL-5 spin labels, we used
the parameters: gxx = 2.0090, gyy = 2.0061, gzz = 2.0026 and
Axx = 6.34 G, Ayy = 5.81, Azz = 33.1 G.3. Results
3.1. Effect of CLPs along the lipid chain
Among the available stearic acid spin labels, four doxyl-
stearic acid derivatives are the most frequently used. In
these derivatives the doxyl group is attached either to the
5th, 7th, 12th or to the terminal 16th carbon. In an attempt to
monitor if there was a region of the lipid chain where the
CLPs alter the membrane fluidity, we measured the EPR
spectra of these spin labels incorporated into the liposomes.
Fig. 2 shows typical EPR spectra of DPPC SUVs labeled by
SL-5, SL-7, SL-12 and SL-16 spin labels. In earlier meas-
urements on human RBCs, we found that CLPs produced a
remarkable effect on the membrane permeability at a lipid-
to-CLP molar ratio of 875–35:1 [26,34,35]. This ratio was
200:1 for the spectra presented in Fig. 2. The molar ratios
were calculated taking into account the number of lipid
molecules, 3.5 10 6 mol, in the outer monolayer of one
RBC [42]. Samples were treated according to the ambient
protocol for 10 min, heated above the pretransition temper-
ature (about 36 jC) and cooled down to ambient tempera-
ture. A remarkable change in the outer-peak separation or in
the ratios of h+ 1/ho was found with each spin label. The
2Amax parameters increased by 5, 6 and 5.5 G in case of SL-
5, SL-7 and SL-12, respectively (standard deviation: 0.4 G),
while the ratio of h+ 1/ho in case of SL-16 decreased by 13%
(standard deviation: 3%). These observations suggest a
substantial decrease of the membrane fluidity along the
whole lipid chain. To investigate whether the different
inactivation characteristics of the pores obtained on RBCs
[26,34,35] were reflected by the fluidity of the structuresFig. 2. EPR spectra of DPPCSUVs: effect of the SP22Aon the lipid fluidity. Spin-lab
-12 and -16 denote the corresponding stearic acid derivatives, labeled at the 5th, 7th,
the positions of the outer extrema, where the outer-peak separation, 2Amax, were dete
which were used in the case of the SL-12 and SL-16 spectra to parameterize the obse
concentration is 10 mg/ml. The SP22A/lipid molar ratio is 1:200. Upper spectrum of
measured on SP22A-treated samples. In the case of SL-12 and SL-16, the measure
respectively.formed, we measured the EPR spectra of the liposomes
treated with SRE using the spin-labeled fatty acids. The
molar ratio of the SRE to the lipids was 1:80, which molar
ratio we found earlier to be effective on RBCs. The EPR
spectra measured (spectra not shown) after same treatment
as with SP22A showed an increase of the outer-peak
separation, similar to that found with SP22A. With ST a
similar effect was found, although the extent of the fluidity
change was less, than with SP22A or SRE. Thus, all the
three toxins studied by us decreased the fluidity of the lipid
bilayer along the whole length of the lipid molecule, which
may be an indication of a pore-formation. These observa-
tions suggest that the differences in the pore inactivation
between SP22A, SRE and ST were not due only to the
decreased fluidity. Further differences, especially those in
temperature dependence, in the created structures and inter-
actions induced by these toxins should also contribute to the
inactivation of the pores.
3.2. Temperature dependence
3.2.1. SUVs
Size distribution of the SUVs was checked by DLS: the
mean hydrodynamic radius of the vesicles was about 30 nm
with a characteristic S.E. value of 12 nm. Samples were
treated on ice with the toxin for less than 10 min according
to the cold protocol. In preliminary experiments, we found
that even an overnight low-temperature incubation did not
change the temperature dependence of the spectra. Temper-
ature was below 10 jC until the start of the measurement.
Samples were measured first in heating cycle by increasing
the temperature from 2 jC to close to or above the cor-
responding pretransition temperature (to 33 jC for DPPC
and to 20 jC for DMPC). Typical temperature increment
was between 2 and 4 jC. No different tendency was
observed with greater increments when the temperature
remained under about 25 jC for DPPC. SP22A increased
the outer-peak separation, which indicates a decrease of
membrane fluidity. The temperature dependence of the
spectra for DPPC SUV (Fig. 3) showed monotonous de-
crease of 2Amax with increasing temperature between 2 and
27 jC. Between 28 and 29 jC there was an abrupt increase
in the value of 2Amax; this indicates an abrupt decrease of
the fluidity. Above 29 jC the 2Amax parameter decreased
again with increasing temperature indicating the increase of
the fluidity. However, the liposome became more rigid in
the treated case than in the control one. Samples were then
cooled down to 2 jC and the EPR spectra were registeredeled stearic acid in a maximal concentration of 1mol%was applied. SL-5, -7,
12th and 16th carbon atom. Straight lines drawn through the spectra indicate
rmined. Also the low-field- and central peak amplitudes, h+1 and ho, are given,
rved changes between the treated and untreated samples. In all cases, the lipid
each pair corresponds to the untreated liposomes, while the bottom ones were
ment temperature was 23 jC, while for SL-7 and SL-5 it was 25 and 27 jC,
Fig. 3. Effect of the SP22A and the SRE treatments on the temperature dependence of the outer-peak separation after cold treatment. SL-5 spin probe and
DPPC SUV were used in both cases. On the main panel, solid squares denote the case control with standard error of mean; open squares correspond to the first
heating cycle (h.c.), when the temperature was raised up to 35 jC in case of SP22A-treated samples. The second heating cycle (solid circles) was initiated after
cooling down the sample to 2 jC. Inset shows the first heating cycle measured on SUV in case control (solid squares) and on the SRE-treated samples (open
squares). The 2Amax values of the second heating cycle are denoted by solid circles. Toxin-to-lipid molar ratios were 1:200 and 1:80 for the SP22A and the
SRE, respectively.
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ence was detected between the outer-peak separations
(2Amax) measured in the two heating cycles with the SL-5
spin probe (Fig. 3). The higher 2Amax values of the second
heating cycle suggested a much smaller fluidity of the lipids
in the second cycle than in the first one. The fluidity
observed in the two heating cycles coincided, however,
beginning from the temperature where the abrupt change
in the first heating cycle occurred. In the case of DPPC
SUVs, the severe change in fluidity begins at about 27 jC,
which is somewhat below the pretransition temperature of
DPPC (f 37 jC). Inspecting the 2Amax values of the two
heating cycles, we found that (a) the increased 2Amax values
measured in the second heating cycle at temperatures lower
than 29 jC did not change in subsequent heating or cooling
cycles, and (b) above the temperature where the maximal
change was found, at about 29 jC, the corresponding values
of the second cycle coincide well with those measured in the
first heating cycle. These observations suggest that the
changes in the fluidity were irreversible.
The inset in Fig. 3 shows the effect of SRE-treatment on
the temperature dependence of the outer-peak separations
measured on SUV samples with SL-5 spin probe. Both
SP22A and SRE considerably decreased the fluidity of the
liposomes close to the head regions. The SRE did not
initiate severe changes around 29 jC in the dynamics of
the lipid head group in the first heating cycle. The
corresponding 2Amax values are 60.61, 61.33 and 61.67 G
for the control, SP22A-treated and SRE-treated sample,
respectively, in the first heating cycle at 2 jC. When thetemperature was increased to 33 jC, we observed the
following 2Amax values: 50.61, 54.39 and 51.83 G for
control, SP22A-, and SRE-treated samples, respectively.
In the second heating cycle, however, the SRE-treated
DPPC samples showed similar characteristics as we
obtained with SP22A, indicating an important change in
the structure or organization of the liposomes. It is accom-
panied by the remarkable change in the 2Amax values, e.g. at
2 jC, SP22A- and SRE-treated samples showed 63.67 and
63.56 G, respectively, or at 33 jC the maximal hyperfine
splitting increased from 51.88 to 52.77 G in SRE-treated
samples.
Similar temperature-dependent effect was observed on
liposomes prepared from DMPC as on DPPC samples;
however, the abrupt fluidity change occurred at lower tem-
peratures. The difference of the 2Amax parameter between
the control and treated samples increased from 1.4 to 2.9 G
at 13 jC, and from 2 to 4 G at 19 jC measured on SP22A-,
and SRE-treated samples, respectively.
3.2.2. MLVs
The temperature dependence of the EPR spectra obtained
with spin-labeled stearic acids for control SUV samples
showed quite different behavior from that observed with
MLVs. The substantial changes of the outer-peak separation
observed for control MLVs around the pretransition were
not present in SUV samples even when SL-5 (Fig. 4) or SL-
7 (data not shown) were used, which monitor the lipid
dynamics close to the polar head group. These temperature
dependences indicate the absence of the formation of a
Fig. 4. Effect of SP22A treatment on SUVs and MLVs of DPPC. Main panel: Temperature dependence of the outer-peak separation for SUVs and MLVs. Open
circles correspond to case control, and open squares denote syringopeptin-treated samples in the second heating cycle. Closed symbols, circles and squares
show the temperature dependence of MLVs for case control and SP22A-treated samples in the first heating cycle, respectively. Inset was generated from the
differences in the outer-peak separations, measured for MLV (closed squares) and SUV (open squares) samples, respectively.
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interaction exists and leads to periodic line defects on the
surface of the MLVs or sonicated large unilamellar vesicles
(LUVs) [43].
Fig. 4 shows the outer-peak separation for the MLV and
SUV DPPC liposomes. Addition of SP22A produces a small
but significant decrease in the fluidity of the multibilayer
structure below about 29 jC. In case of the SP22A-treated
samples the fluidity of both the SUVs and the MLVsFig. 5. Temperature dependence of outer-peak separations for SUVs prepared fr
protocol. Symbols given on the main panel are valid also for the inset.decreased above 29 jC up to the main transition as reflected
by the increase of 2Amax relative to the controls. Above the
main transition, the fluidity of the two types of liposomes
coincides and there was only a small (about 0.4 G) differ-
ence in the 2Amax values of the SP22A-treated samples. The
value of 2Amax changed by more than 7 G at 23 jC in the
case of SP22A-treated SUV samples, while the change was
smaller (f 1 G) and shifted to 37 jC for SP22A-treated
MLV samples (inset in Fig. 4). These observations suggest aom DPPC and DMPC. Effect of SP22A treatment according to the warm
Fig. 6. Dependence of the syringopeptin effect on the lipid composition.
Differences in the outer-peak separations between the case control and the
first heating cycle of the given sample are normalized for the greatest
difference measured in case of syringopeptin-treated DPPC alone. (A)
Cholesterol–DPPC SUVs were prepared with 0, 15, 30 and 40 mol% of
cholesterol to DPPC. The Cholesterol–DPPC liposomes were treated with
a SP22A concentration of 1:200 (SP22A-to-lipid molar ratio) according to
the cold protocol. (B) DOPC–DPPC SUVs were prepared with 0, 5, 15 and
30 mol% of DOPC to DPPC. The DOPC–DPPC liposomes were treated in
a SP22A-to-lipid molar ratio of 1:200 according to the cold protocol.
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with liposomes, i.e. the change of the fluidity due to the
interaction between the CLPs and the liposomes was influ-
enced by the actual fluidity of the liposome itself.
The change of the fluidity observed with increasing
temperature, in the direction of the gel-to-fluid transition,
could be interpreted as the consequence of temperature
dependence of the amount of CLPs, which penetrate into
the liposomes’ bilayer. At higher temperature, more CLP
would penetrate, which would result in a stronger interaction
between the CLPs and the lipids. To study this possibility,
the temperature dependence of the spectra was also regis-
tered in a reversed cycle when the samples were cooled.
3.2.3. Temperature dependence in cooling cycle
Samples were prepared according to the warm protocol
(see Materials and methods) and measured in a cooling
cycle and in a subsequent heating cycle. Fig. 5 shows
typical runs for DPPC- and DMPC SUVs that were treated
with SP22A in a molar ratio of 1:200 (SP22A/lipid). The
measured 2Amax values indicated that in the cooling cycle
the fluidity of the sample was greater than in the subsequent
heating cycle. In case of DPPC, the difference between the
fluidities of the cooling cycle and the subsequent heating
cycle became smaller, approaching the temperature of the
maximal change found in the first cooling cycle (f 29 jC).
To check whether this phenomenon can be attributed to a
hysteresis, we prepared DPPC–SP22A samples according
to the cold protocol and measured them after the heating
cycle in a cooling cycle. In the cooling cycle, we found only
a minimal hysteresis, which observation differs from the
temperature dependence of the spectra given in Fig. 5.
The inset in Fig. 5 shows similar measurement cycling
for DMPC. In the cooling cycle, the measured outer-peak
separations (2Amax) coincide closely with the data measured
for the control samples, whereas in the subsequent heating
cycle a remarkable difference was observed.
3.3. Effect of cholesterol
Earlier studies on model membranes and on RBCs
demonstrated that different sterols modulated the effect of
the CLP. Depending on the composition and the species
studied, sterols could enhance or diminish the CLPs’ effect
[9,27,28,31,32,45,46]. In this study SUVs of DPPC–cho-
lesterol were prepared and labeled with the SL-5 spin probe.
Fig. 6A shows the results, which correspond to the exper-
imental points measured in the first heating cycle. Three
different concentrations of the cholesterol were used: 15, 30
and 40 mol% relative to the host DPPC. To characterize the
combined effect of the cholesterol and SP22A, we defined
the relative change of the outer-peak separation as D2Amax/
max(D2Amax). The term D2Amax denotes the change in the
2Amax value measured after SP22A treatment of the sam-
ples. The other term, max(D2Amax), corresponds to the
maximum of the temperature-dependent changes in the2Amax values measured for DPPC samples without choles-
terol. The defined ratio is 1.0 at the maximum of the change,
which occurs at about 29 jC for cholesterol-free sample
(Fig. 6A). In the absence of SP22A, the fluidity of the SUV
samples decreased relative to the DPPC case control at all
cholesterol concentrations, which was reflected by the
increased 2Amax values. The observed decrease depended
on the cholesterol concentration: higher concentrations
provoked greater decrease in the fluidity. Upon addition of
the SP22A, a further decrease was observed in the fluidity
(Fig. 6A), but this subsequent change became smaller as the
cholesterol content increased.
3.4. Effect of DOPC
In addition to the saturated phospholipids, unsaturated
lipids also contribute to the composition of the biological
Fig. 7. Change of the maximal hyperfine splitting as the function of the
CLP concentration. SUV samples of 10 mg/ml concentration were treated
according to the cold protocol and measured in the first heating cycle at 23
jC. D2Amax values denote differences between the case control and the
treated sample.
Table 1
Best-fit parameters of Rprp and S20 from NLLS fits for ESR spectra of
DPPC liposomes labeled with SL-5
Control First heating cycle Second heating cycle
S20
a 0.49 0.52 0.67
Rprp [s
 1]b 5.56 107 4.57 107 3.47 107
Values given in the table were determined with EPR spectral simulations.
The fitted experimental spectra were measured at 27 jC. DPPC samples
were treated with syringpopeptin 22A in a toxin-to-lipid ratio of 1:200.
a Value of the S.E. is F 0.01.
b Range of the S.E. is F 5% for the determination of the rotational
correlation time.
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lipids, the DOPC is one of the most studied. Therefore, we
studied the effect of DOPC on the temperature dependence
of the SUV samples treated with SP22A. Fig. 6B shows
how the DOPC/DPPC ratio of the liposome composition
influences the effect of SP22A in a heating cycle. At 5%
DOPC content, there was still severe changes in the fluidity.
However, the maximum of the differences between the
SP22A-treated and untreated DOPC/DPPC samples shifted
to lower temperature (from 29 to 21 jC). The abrupt
irreversible change, which was observed with pure DPPC
samples, disappeared when the proportion of the DOPC was
increased to 15%, indicating that the difference was much
smaller between the SP22A-treated and untreated DPPC/
DOPC liposomes. In case of the SUVs, which contained
30% DOPC, we observed only little difference between the
CLP-treated and untreated samples (Fig. 6B).
3.5. Concentration dependence of fluidity change in SP22A-
and SRE-treated liposomes
Concentration dependence of the CLP-lipid interaction
was studied at 23 jC (Fig. 7), below the temperature of the
rigidity step, which occurs for DPPC SUV samples at about
29 jC (see Fig. 3). Our argument to observe the concentra-
tion dependence below this temperature is that: (a) the
temperature of the irreversible fluidity step varies depending
on the toxin; (b) at 29 jC even a SP22A/lipid ratio of 1:200
provoked a great change in the outer-peak separation. Fig. 7
shows that for both SP22A and SRE, the effect of CLP is
detectable at least at a CLP/lipid ratio of 1:400. We were
also able to detect similar decrease of the fluidity at the
middle of the hydrocarbon chain with the SL-12 spin probe.
It is detectable even for the SRE, which according to our
measurements induces smaller change than the SP22A at the
same concentration.4. Discussion
4.1. Pore-formation by CLPs of P. syringae pv. syringae
According to earlier measurements, the CLPs form pores
on RBC- and model membranes [7,9,33–35,47–49]. In
agreement with our experimental observations, our spectral
simulation revealed an increased ordering and hindered
rotation of the lipid molecules when they interacted with
CLPs. Table 1 contains some indicative data for the calcu-
lated order parameters and rotational correlation times. The
phenomenon that CLPs increased the order along the whole
lipid-chain corresponds to the observations [6,8–10] that
CLPs induce pores. Based on single-channel measurements
a recent hypothesis proposed [33] that the pores formed by
the SRE were built up from a lipid core stabilized by the
toxin molecules. On the bases of simple geometrical model,
it has also been proposed that the number of lipid molecules
involved in a pore created by one SRE monomer was
roughly 40. In the present work, CLP/lipid molar ratios
between about 1:40 (2.5 mol%) and 1:800 (0.125 mol%)
were investigated with SP22A and SRE. In the case of
SP22A and SRE, the EPR spectra have shown a significant
change in the fluidity, beginning from the CLP/lipid ratio
f 1:400. Inspection of the spectra measured for these cases
showed no sign of two lipid populations, which would
belong to bulk and ‘‘pore’’ lipids. In accordance with the
experimental spectra, also our spectral simulations proved
no sign of a two-component spectrum in case of any spin
label. Lack of observing two component spectra in gel phase
membranes, however, does not necessarily mean involve-
ment of the majority of the lipids in pore-formation. Ability
to detect two components of different mobility is determined
by at least two factors: (a) exchange rate between ‘‘bound’’
and bulk lipids; (b) the difference in the correlation times/
ordering potential of the two compartments [50]. Time scale
of the molecular motions in gel phase membranes corre-
sponds rather to the time scale of the ST-EPR spectroscopy
[51,52]. Thus, experimental determination of the bulk/
bound ratio would require detailed ST-EPR measurements,
which, however, is beyond the scope of the present work.
Lipid–protein interaction was studied mainly on proteins
of much greater molecular weight then the CLPs, e.g. avidin
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greatest CLP in our study, SP22A, has that of 2200. This
difference in molecular dimension can suggest that the
primary shell of lipids, nearest to the CLPs, can build up
a highly ordered domain that, together with the toxin, exerts
aligning potential for the subsequent shells of lipid mole-
cules. In case of SUVs, this event can lead to a continuous
change of the molecular ordering and the rotational corre-
lation time of the lipids along the shells. The observed EPR
spectrum is then the average of a great number of highly or
moderately ordered lipid molecules, for which the estimated
number of 40 may be the minimal estimate. This explana-
tion may also suggest that pores formed by CLPs may be
built up from varying number of lipid molecules. The
number of lipid molecules involved in one pore can depend
on the lipid composition of the membrane.
We were also faced to the question if there is a specific
interaction between the spin-labeled stearic acid derivatives
and the CLPs, which can lead to preferential or specific
involvement of the spin label molecules in pore formation,
hence selective interaction of different lipids are well
documented in the works of Marsh’s group [53]. Thus, the
EPR spectra were not representative of the whole membrane
but only to the specific interaction between the toxin and
spin labels. A verification for the exclusion of the above
possible specific interaction is the use of, e.g. spin-labeled
phosphatidyl-choline. In a control experiment with SL-
SPPC using SP22A in a CLP/lipid ratio of 1:100, we
observed similar change in the membrane fluidity as with
the spin-labeled stearic acid derivative. Although this simple
test gives evidence that CLPs have an effect on DPPC below
the main transition, it does not completely exclude that the
large effect observed using SL spin labels is the result of the
combined effects on the host lipid and the specific interac-
tion between CLPs and SL spin probes.
4.2. Heating vs. cooling cycle
The DPPC and DMPC samples prepared according to the
cold protocol and measured in the first heating cycle showed
an abrupt irreversible decrease of the fluidity at a temperature
characteristic for the lipid species. This phenomenon could
have been attributed to temperature-dependent changes in
the incorporation depth of the CLPs. In this case, the SP22A-
treated samples, prepared according to the warm protocol,
should have shown high 2Amax values due to the great
amount of SP22A that entered into the membrane. Inconsis-
tent with this hypothesis, the 2Amax values, measured in the
cooling cycle (Fig. 6) above the main transition temperature
of the DPPC or DMPC, were close to the control values.
Significant differences in the 2Amax values between the
control and the treated samples were detected only close to
the pretransition temperature in case of the DPPC. Accord-
ingly, the abrupt change of the fluidity cannot be explained
by the change in the incorporation depth. It seems that the
change in the fluidity occurs close to the pretransition withina relatively narrow temperature range. EPR spectra of the
SRE-treated samples measured in heating cycle after cold
treatment showed similar irreversible change as the samples
treated with SP22A, although the required temperature was
higher (36 jC) than with SP22A. These suggest that specific
molecular interaction presumably between both the head
groups and the hydrocarbon chains are required for the
abrupt fluidity change. The hydrophobicity of the SRE is
smaller than that of SP22A, which can be responsible for
difference between the transition temperatures, and it can
explain that the SP22A may exert the strongest impact on the
ordering and mobility of the lipid molecules among the three
toxins. Temperature dependence of effect on the fluidity of
the three toxins, together with the concentration dependence
of their ordering activity, may provide a reasonable expla-
nation for the differences of the pore inactivation. Inactiva-
tion can be thought as disruption of the pores due to the
lower alignment and greater motional freedom of the lipid
molecules in the case of SRE and ST than for SP22A.
4.3. Influence of cholesterol and DOPC in CLP action
Among other techniques DSC, X-ray and spectroscopic
measurements have shown that cholesterol increases the
hydration of the headgroups, increases the acyl chain order-
ing and reduces the water penetration [54–59]. Studying
calcein efflux from LUVs using syringopeptins, syringomy-
cin-E and ST, the minimal CLP-to-lipid ratio was 1:10 in the
work of Dalla Serra et al. [9]. The effect of SP22Awas found
maximal even without sterols, but SRE and ST have shown
an increase in their activity if specific sterols were used
preparing the LUV. According to our present results, the
cholesterol (Chol) was not necessary to induce a remarkable
change in the fluidity of the SUV interacting with CLPs.
Instead, the largest relative decrease in the fluidity was found
without adding cholesterol.
In our measurements (data not shown here), we
observed that Chol decreased the membrane fluidity
proportional to its increasing concentration in DPPC–
Chol SUV samples. What may be the origin of the results
that with increasing Chol content we observed a decreas-
ing extent in the CLP rigidifying effect? A possible
explanation is that there is an upper limit for the ordering
and reduced mobility of the lipid molecules at a given
temperature. This corresponds to the case of the MLV,
where the lipid ordering is the highest one due to the
inter- and intrabilayer forces. Indeed, in the case of MLV
compared to SUV we observed a smaller apparent de-
crease of the fluidity, induced by SP22A (Fig. 4).
It seems, therefore, that the presence of the cholesterol/
sterols is not a prerequisite for the CLP action, at least not in
its action to build up ordered shells from lipid molecules of
increased ordering. The lower effect of SP22A on choles-
terol-containing SUVs is in agreement with the study [32],
which showed that on cholesterol-depleted RBCs the pore-
forming activity of SRE was higher than on control RBCs.
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bilayer conductance induced by SRE was about 1000 times
less in bilayers containing 50 mol% of cholesterol than in
bilayers without sterols [31].
Biological membranes contain significant amount of
unsaturated lipids, from which the most studied is the
DOPC. Its main transition temperature is about  22 jC
[60]. The hydrocarbon chain of DOPC possesses greater
motional freedom than that of DPPC due to the unsaturated
bond in DOPC [61]. Permeability measurements on RBCs
and on BLMs—prepared from DOPS/DOPE binary mix-
tures—proved, however, that pores exist also in that case
and the pore’s lifetime decreases with increasing fluidity
[7,8,26,32–35]. Our results show that as far as the temper-
ature was increased close to the main transition temperature,
which corresponds to an increased fluidity, the difference
between the treated and untreated DPPC samples dimin-
ished. Thus, the greater motional freedom can decrease the
ability of the CLPs to order the lipids in the DOPC–DPPC
mixtures to the extent observed with DPPC alone. This
explains that although the pores can exist at relatively high
thermal fluctuation, the difference between the EPR spectra
of the ordered and disordered lipids becomes very small,
which leads to almost no difference between the EPR
spectra of the treated and the untreated samples.
4.4. Coalescence, aggregation
Our data suggested that the fluctuations in the highly
curved SUVs did not allow the ordering of the chain
melting-induced point defects into line defects that were
necessary for the pretransition [43,44]. In the case of SUVs,
there is no bilayer–bilayer interaction; the out-of-plane
fluctuations are less confined than in the case of MLVs or
LUVs, and only those curvature fluctuations are allowed,
which maintain the closed topology [43].
Temperature dependence of the fluidity of the SP22A-
treated DPPC SUV samples in the second heating cycle was
very close to that one observed with MLVs (Fig. 4). These
results suggest the appearance of such new structures in the
interaction with CLPs, which make possible the inter-bilayer
interactions, and stronger surface confinements and can
result in: (a) increase of the vesicle radius; (b) induce
aggregation. Both cases can lead to formation of the ripple
structure in the treated samples, thereby approaching the
temperature dependence observed for a more ordered and
confined liposome system, the MLV. Indeed, in the case
when we detected the abrupt irreversible change of the
fluidity, careful check of the CLP-treated samples showed
increased turbidity and aggregation of the vesicles. An
increase of the vesicle radius can be resulted in either by
fusion or coalescence of the unilamellar vesicles. Our
preliminary DLS and EPR measurements showed that apart
from aggregation, coalescence of the SUVs occurred at
temperatures somewhat below the pretransition when
SP22A, SRE or ST interacts with SUVs (data are notshown). These observations do not exclude the possibility
of vesicle fusion.5. Conclusion
Our experimental works and computer simulations have
shown that pore formation caused by SP22A, SRE and ST
likely involves lipid molecules aligning them in ordered,
motionally constrained structure. The number of lipid mol-
ecules involved in a pore may vary depending on the CLP
species, concentration, and the lipid composition of the
membrane. Comparing MLVs and SUVs, we observed that
the ability of the CLPs to order the lipid molecules involved
in pore formation depends also on the motional freedom of
the lipid molecules constrained by the specific interactions
acting in the liposomal structures. The highest activity to
modify lipid ordering was found for SP22A, while SRE was
less active and ST the least one. Cholesterol increased, while
DOPC decreased the ordering of the lipid molecules in SUVs
and both limited the additional ordering effect of the SP22A
on the lipid molecules. Comparing EPR spectra measured in
heating and cooling cycles for DPPC and DMPC samples,
we have shown that the abrupt change in the fluidity
measured on CLP-treated SUVs occurred within a limited
range of temperatures. This fluidity change is due to coales-
cence and aggregation of the SUVs, which can have impor-
tance in bacterial attack. Further efforts are required to
understand the effect of different sterols and the phenomenon
of fusion/coalescence.Acknowledgements
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